AbbVie’s Skyrizi drug to treat psoriasis wins U.S. approval

FILE PHOTO: A trader works by the post that trades AbbVie on the floor of the New York Stock Exchange March 5, 2015. REUTERS/Brendan McDermid/File Photo

(Reuters) – AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.

Plaque psoriasis is the most common form of psoriasis, a chronic skin condition.

The approval of Skyrizi, an injectable drug, is based on results from AbbVie’s global Phase 3 psoriasis program, which assessed the safety and efficacy of the drug in adults with moderate to severe plaque psoriasis.

AbbVie said it expects Skyrizi to be available in the United States in early May.

Psoriasis causes an overproduction of skin cells, resulting in inflamed, red lesions or plaques, which can be itchy and painful. It affects 7.5 million Americans and is the most prevalent autoimmune disease in the United States, AbbVie said.

Humira is the world’s best-selling prescription medicine and has long buoyed AbbVie’s business, bringing in revenue of $19.94 billion in 2018. But it is set to face biosimilar competition from 2023.

Skyrizi, which won regulatory approval in Canada and Japan earlier this year, is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization of the drug.

Reporting by Aakash Jagadeesh Babu and Shanti S Nair in Bengaluru; Editing by Leslie Adler

Source

more recommended stories

  • AstraZeneca diabetes drug shows promise in heart failure

    (Reuters) – AstraZeneca (AZN.L) made strides.

  • Study prompts call for lower fluoride consumption by pregnant women

    (Reuters Health) – Adding fluoride to.

  • CDC investigates lung illnesses linked to e-cigarette use

    FILE PHOTO: A man vapes outside.

  • E.coli in water forces Tokyo to cancel swimming at Paratriathlon World Cup

    TOKYO (Reuters) – High levels of.

  • E.coli risk forces Tokyo to cancel swim events at Paratriathlon World Cup

    TOKYO (Reuters) – High levels of.

  • First two Ebola cases confirmed in Congo’s South Kivu – officials

    FILE PHOTO: Children look at a.

  • Surgical training programs not supportive of new parents

    (Reuters Health) – Surgical residents say.

  • Liver disease related to obesity and diabetes rising in U.S.

    (Reuters Health) – The only liver.

  • Ebola ‘no longer incurable’ as Congo trial finds drugs boost survival

    LONDON (Reuters) – Scientists are a.

  • Scientists hail promise of first effective Ebola treatments in Congo trial

    LONDON (Reuters) – Scientists are a.

  • China cuts 2019/20 corn use forecast by 2 million tonnes due to African swine fever

    Corn kernels are seen at a.

  • WHO says no new Ebola cases in Goma, vaccinates over 1,300

    FILE PHOTO: A young woman reacts.

  • Dengue death toll rises in Malaysia, number of cases close to double

    KUALA LUMPUR (Reuters) – Malaysia saw.

  • Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis

    (Reuters) – A U.S. judge on.

  • AstraZeneca’s Tagrisso helps lung cancer patients live longer: study

    (Reuters) – AstraZeneca Plc said on.

  • Study shows Apple devices in combo with apps could identify dementia

    FILE PHOTO: The new Apple iPhone.

  • Moving during early pregnancy may increase preterm birth risk

    (Reuters Health) – Moving to a.

  • Drug assistance programs offer little charity to uninsured

    (Reuters Health) – Many patients who.

  • In extreme heat, electric fans inadvisable unless it’s humid

    In extreme heat, electric fans may.

  • Trump administration considers September unveiling of healthcare plan: WSJ

    FILE PHOTO: U.S. President Donald Trump.

  • Bulgaria to compensate owners who cull pigs to help stamp out swine fever

    FILE PHOTO: A pig rests at.

  • Yellow lens glasses don’t improve drivers’ night vision

    (Reuters Health) – – Touted to.

  • U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor

    (Reuters) – The U.S. Food and.

  • For some surgeries, hospital rankings not tied to better outcomes

    (Reuters Health) – When it comes.

  • Congo says Rwanda has closed border near Goma

    Congolese customs agents gather at the.

  • Pluristem gets positive results from radiation treatment trials

    TEL AVIV (Reuters) – Israel’s Pluristem Therapeutics.

  • Congress seeks briefing on potential threat to U.S. heparin supply

    WASHINGTON (Reuters) – Leaders of the.

  • U.S. judge blocks Medicaid work requirements in New Hampshire

    (Reuters) – A federal judge on.

  • Bernie Sanders visits Canadian pharmacy, talks drug prices

    WINDSOR, Ontario (Reuters) – U.S. Senator.

  • China detects African swine fever in pigs transported to Liaoning: Xinhua

    BEIJING (Reuters) – China detected African.

  • Sanofi ends partnership with Lexicon to develop diabetes drug

    FILE PHOTO: A logo of Sanofi.

  • WHO says it could use more U.S. help on the ground in Ebola fight

    GENEVA (Reuters) – The United States.